{"version": "https://jsonfeed.org/version/1.1", "title": "Sharemaestro Newsreel: Switzerland Specialty Chemicals news", "home_page_url": "https://sharemaestro.com/newsreel/ch/basic-materials/specialty-chemicals/", "feed_url": "https://sharemaestro.com/newsreel/ch/basic-materials/specialty-chemicals/feed.json", "description": "Latest Specialty Chemicals company headlines from Switzerland, newest first, with source links and direct routes to company research and sentiment.", "language": "en", "items": [{"id": "source:42a629e691055a42ec13ef8bc6f0f3c3d31f7b2c7e8038507a15807a75e34ff2", "url": "https://finance.yahoo.com/healthcare/articles/market-chatter-novartis-wins-uk-153302721.html", "external_url": "https://finance.yahoo.com/healthcare/articles/market-chatter-novartis-wins-uk-153302721.html", "title": "Update: Market Chatter: Novartis Wins UK Court Challenge to Entresto Patent", "content_text": "(Updates with response from a Novartis spokesperson in the fourth and fifth paragraphs.)Novartis (NVS) defeated a bid by Accord Healthcare to invalidate its Entresto patent, with a UK court ruling that the patent and a related protection certificate remain valid, Reuters reported Silver Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade now", "date_published": "2026-08-13T15:33:02+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Analyst action", "EMSN"], "_sharemaestro": {"country": "Switzerland", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "EMSN", "name": "EMS-CHEMIE HOLDING AG", "sentiment_url": "https://sharemaestro.com/sentiment/12f49923-55c4-41ca-90eb-c40744f4fa80/"}]}}, {"id": "source:5f7cabe09de35a66efd2b5182820711930d63911999c36dc13c6ed2b1a87e2b8", "url": "https://finance.yahoo.com/markets/stocks/articles/following-evoniks-24-q2-ebitda-080200819.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/following-evoniks-24-q2-ebitda-080200819.html", "title": "Following Evonik's 24% Q2 EBITDA Surge and Raised 2026 Outlook, New Report Outlines Trajectory for Sustainable Polymeric Surfactants", "content_text": "Company Logo Accelerating industry transition toward environmentally compliant, low-VOC, and bio-based formulations highlighted by BASF's raised 2026 financial guidance, Evonik's 24% Q2 EBITDA surge, and Clariant's Care Chemicals margin expansion is propelling the global polymeric surfactants market toward a projected $17.8 billion by 2035. This 220-page study delivers an in-depth analysis of polymer architectures (block copolymers, graft copolymers, complex architectures), application areas (emulsification, dispersion, wetting, stabilization), end-use industries (coatings, personal care, agri", "date_published": "2026-08-13T08:02:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "CLN"], "_sharemaestro": {"country": "Switzerland", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "CLN", "name": "Clariant AG", "sentiment_url": "https://sharemaestro.com/sentiment/68b785d1-b026-4e3c-8ce9-4242f55660c2/"}]}}, {"id": "source:925017f4be8893e31a12586289c34f0c7ee514ff04b91b00d8b70dac2f840033", "url": "https://finance.yahoo.com/energy/articles/cez-xpra-cez-q2-2026-011013959.html", "external_url": "https://finance.yahoo.com/energy/articles/cez-xpra-cez-q2-2026-011013959.html", "title": "CEZ AS (XPRA:CEZ) (Q2 2026) Earnings Call Highlights: Net Income Rises 10% as Windfall Tax ...", "content_text": "This article first appeared on GuruFocus. Revenue: Operating revenue decreased 5% year-on-year, primarily due to lower power prices. EBITDA: Down 20% to CZK59 billion, impacted by lower generation prices and reduced trading profits. Net Income: Increased 10% to CZK18.1 billion, driven by the absence of the windfall profit tax, which ended on December 31, 2025. Operating Cash Flow: Increased by CZK26 billion, or 55% year-on-year. Capital Expenditures (CapEx): Increased 30% year-on-year. Net Debt: Approximately 9% higher, approaching CZK200 billion. Generation and Mining EBITDA: Decreased by CZK14.5 billion, or 31%, due to lower power prices. Coal Generation EBITDA: Down 65% to CZK1.4 billion, despite similar production volumes. Distribution EBITDA: Increased by CZK2 billion, or 10%, with normalized electricity EBITDA up 15% and gas distribution normalized EBITDA up 25%. Sales Segment EBITDA: Decreased by CZK2.4 billion, partly due to lower margins in retail and wholesale. Income Tax: Fell to CZK5.5 billion from CZK23.1 billion, reflecting the removal of the windfall profit tax. Guidance (EBITDA): Raised to CZK109 billion to CZK114 billion from CZK107 billion to CZK112 billion. Guidance (Adjusted Net Income): Raised to CZK31 billion to CZK35 billion from CZK30 billion to CZK34 billion. Nuclear Generation: 15.3 terawatt-hours generated in the first half, with a full-year target of 30.6 terawatt-hours. Fossil Fuel Generation: Up 6% in the first half, with full-year coal generation expected to increase 9% and natural gas by 87%. Hedging: 76% hedged for 2027 at an average price of EUR88 per megawatt-hour. Warning! GuruFocus has detected 9 Warning Signs with XPRA:CEZ. Is XPRA:CEZ fairly valued? Test your thesis with our free DCF calculator. Release Date: August 11, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Net income increased 10% year-on-year to CZK18.1 billion, driven by the end of the windfall tax. Operating cash flow rose 55% to CZK26 billion, providing strong liquidity. Distribution segment EBITDA grew 10%, with normalized electricity EBITDA up 15% and gas up 25%. Nuclear generation exceeded expectations, with 15.3 TWh produced in H1 and full-year guidance raised. Guidance for 2026 EBITDA and adjusted net income was raised by CZK2 billion and CZK1 billion, respectively. Negative Points EBITDA declined 20% to CZK59 billion, primarily due to lower power prices. Generation and mining segment EBITDA fell 31%, with coal EBITDA down 65%. Sales segment EBITDA decreased by CZK2.4 billion, impacted by lower margins and project delays. Trading profits were lower, with a negative revaluation of derivatives of CZK2.6 billion. Net debt increased 9% to nearly CZK200 billion, raising leverage concerns. Story Continues Q & A Highlights Q: Can you elaborate on the trading results, which were negatively impacted by derivative revaluations, and discuss the risk of windfall taxes being reintroduced given the current high power prices?A: Pavel Cyrani (Vice Chairman, Head of Sales and Strategy) explained that most of the trading effect is due to intra-year revaluation of energy contracts, which can swing between positive and negative (e.g., +CZK2.6 billion at the end of Q1 vs. -CZK2.6 billion now). He noted that 2026 is a slower year for base trading but expects a recovery to standard levels. Martin Novak (CFO) stated that windfall tax reintroduction is not on the table, as energy company profits are significantly lower than when the tax was introduced, and such a move would impair discussions about new projects and the CEZ Energy separation. Q: What is driving the positive performance in the Distribution segment, and how should we read across to 2027 regarding correction factors?A: Pavel Cyrani (Vice Chairman, Head of Sales and Strategy) attributed the outperformance to higher-than-expected consumption due to a colder winter and underlying recovery in industrial and hous", "date_published": "2026-08-13T01:10:13+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "GIVN"], "_sharemaestro": {"country": "Switzerland", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "GIVN", "name": "Givaudan SA", "sentiment_url": "https://sharemaestro.com/sentiment/ae280d62-8f03-44ca-adf8-a4acf0559370/"}]}}, {"id": "source:75002d510a976d8fb1fd26d66ac0ca94ee02132e471459632ecb609c35c42bda", "url": "https://finance.yahoo.com/technology/ai/articles/gft-technologies-se-wbo-gft-010536877.html", "external_url": "https://finance.yahoo.com/technology/ai/articles/gft-technologies-se-wbo-gft-010536877.html", "title": "GFT Technologies SE (WBO:GFT) (H1 2026) Earnings Call Highlights: AI-Driven Growth and ...", "content_text": "This article first appeared on GuruFocus. Revenue: EUR462.6 million in H1 2026, a 5% increase in both euros and constant currencies. Adjusted EBIT: EUR33 million, up 8% year-over-year, with a margin of 7.1% compared to 6.8% in H1 2025. EBT: EUR24 million, up 26% year-over-year, with the EBT margin improving from 4.3% to 5.2%. Q2 Revenue: EUR233.04 million, a 6% increase versus Q2 2025. Q2 Adjusted EBIT: EUR16.5 million, a 10% increase versus Q2 2025. Order Backlog: Up 18% versus last year. Wynxx Soft Engineering Revenue: EUR24.4 million in actual influenced revenue in H1 2026. Wynxx Business Process Revenue: EUR14.8 million in actual influenced revenue in H1 2026. Wynxx Total Influenced Contract Value: Over EUR144 million since inception, representing 38% growth quarter-over-quarter. Operating Cash Flow: Minus EUR1 million, an improvement from minus EUR9 million in the prior year. Free Cash Flow (Adjusted): Improved to minus EUR8.3 million from minus EUR17.3 million a year ago. Employees: 11,805 at the end of June, flat versus the beginning of the year and up 3% versus June last year. Utilization Rate: Increased to 92.8%. Attrition: Reduced to 10.4%. Warning! GuruFocus has detected 7 Warning Sign with WBO:GFT. Is WBO:GFT fairly valued? Test your thesis with our free DCF calculator. Release Date: August 06, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points GFT Technologies SE (WBO:GFT) reported solid revenue growth of 5% in H1 2026, with strong performance in key markets like Brazil (38%), Colombia (27%), Switzerland (22%), and Spain (13%). Profitability improved significantly, with adjusted EBIT up 8% to EUR33 million and EBT up 26% to EUR24 million, reflecting better earnings quality and disciplined execution. The Wynxx Agentic AI platform is scaling rapidly, with 113 clients, 12 countries, and total influence contract value reaching EUR144 million, up 38% quarter-over-quarter. The company won six next-generation core banking programs and a major AML platform go-live for a Tier 1 European bank, demonstrating strong domain expertise and client trust. The order backlog increased by 18%, driven by multi-year contracts, including SAP business in Brazil, providing strong visibility for future growth. Negative Points Revenue in Germany declined by 12% due to investment caution, and the UK business was down 18% in H1, though expected to return to growth in Q3. North America revenue declined 7% due to a low-margin pass-through business in Canada and unfavorable FX, with Canada down 12% in euro terms. Operating cash flow was negative at EUR1 million in H1, reflecting seasonality and working capital tied up in contract assets, though improved from last year. The company faces headwinds from FX in North America, which could impact revenue, though offset by tailwinds in Latin America. Internal AI token costs are rising, with an expected spend of around EUR1 million this year, requiring careful management and pricing adjustments. Story Continues Q & A Highlights Q: Can you provide a bridge for the adjusted EBIT guidance, specifically what to expect for M&A and capacity adjustments in H2, and what needs to happen to reach the 7.6% full-year margin from the 7.1% seen in H1? A: Jochen Ruetz (CFO): We expect FX-adjusted EBIT to be roughly flat in the second half. Capacity adjustments should be similar to H1, around EUR3.5 million. To reach the full-year margin, we will repeat the pattern of the last few years, with a stronger second half driven by more billable days, especially in South America. We expect a logical second-half margin of roughly 8% to achieve the overall guidance. Q: Where do you see the market cycle for bank-related IT services, and is sentiment improving? Also, did the six next-gen core banking projects significantly contribute to the strong order backlog growth? A: Marco Santos (CEO): We see improving sentiment among financial services clients, particul", "date_published": "2026-08-13T01:05:36+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "GIVN"], "_sharemaestro": {"country": "Switzerland", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "GIVN", "name": "Givaudan SA", "sentiment_url": "https://sharemaestro.com/sentiment/ae280d62-8f03-44ca-adf8-a4acf0559370/"}]}}, {"id": "source:89ccdae8021599987b6aa5f490674f932ae2eb912f9372cd9d18a81117ea95ac", "url": "https://finance.yahoo.com/real-estate/articles/nextensa-delivers-strong-half-results-155500459.html", "external_url": "https://finance.yahoo.com/real-estate/articles/nextensa-delivers-strong-half-results-155500459.html", "title": "Nextensa delivers strong half-year results, supported by several successful transactions", "content_text": "Nextensa NV PRESS RELEASE Regulated information Brussels, 12 August 2026, 5:55PM HIGHLIGHTS Nextensadeliversstronghalf-yearresults,supportedbyseveralsuccessful transactions Nextensa achieved strong results in the first half of 2026. The period was marked by several successful transactions, including the sale of Gewerbepark Stadlau in Vienna, the forward sale of The Rock and the sale of B&B Hotels in Cloche d'Or. The granting of the planning and environmental permits for Lake Side in Brussels and the reservation by Vicinity of a substantial residential portion of Bel Towers further underline the strong progress of the development portfolio. After the end of the half-year, further important milestones were reached with the sale of the Stairs office building in Cloche d'Or and the European Investment Bank (EIB) Group's selection of Treemont. Portfolio optimisation and opertaing performance On 14 January 2026, Nextensa completed the sale of the Gewerbepark Stadlau retail park in Vienna for net proceeds of \u20ac35.45 million. The transaction forms part of the continued optimisation of the investment portfolio. The operating result from investment properties decreased compared with the same period last year, due to lower rental income and lower property costs following several disposals in 2025. The investment portfolio recorded a 5.7% like-for-like decline in rental income in H1 2026, mainly as a result of anticipation of Proximus's arrival at Tour & Taxis. Strong momentum in development activities Cloche d'Or also saw several important transactions in the first half of 2026, including the forward sale of The Rock building, signed on 16 April, and completion of the sale of B&B Hotels, signed on 7 May. The sale of the Stairs office building was finalised on 1 July. Net result Lower overheads and lower financing costs resulted in a net profit (Group share) of \u20ac16.6 million (\u20ac1.68 per dividend-entitled share), compared with \u20ac19.9 million at 30 June 2025. Further improvement in the financial position Net financial costs, excluding revaluation effects, decreased by \u20ac2.8 million compared with the same period last year, mainly due to lower average debt utilisation. Net financial debt amounted to \u20ac550.3 million at the end of Q2 2026, compared with \u20ac592.8 million at the end of 2025 and \u20ac769.3 million at the end of 2024. Story Continues The average financing cost decreased from 2.90% to 2.65%, while the hedge ratio remained high at 97%. The financial debt ratio improved from 38.80% at the end of 2025 to 37.88% at the end of Q2 2026. This ratio does not yet take into account available cash of \u20ac31 million. Nextensa maintains a strong liquidity position, with approximately \u20ac205 million of undrawn committed credit facilities, enabling it to refinance the \u20ac100 million bond maturing in November 2026 through existing credit lines. \"We are not just developing real estate; we are building sustainable urban neighbourhoods that create lasting added value for their surroundings. The progress we are making today in Brussels, with Lake Side at Tour & Taxis and Bel Towers in the Northern Quarter, and in Luxembourg with Cloche d'Or, confirms that we are realising our long-term ambition step by step. Our strengthened balance sheet gives us the capacity to continue these projects and keep creating sustainable value for all our stakeholders.\" Michel Van Geyte - CEO Nextensa Attachment 8986_NEX_Persbericht Q2 Results_ENG_Def View Comments", "date_published": "2026-08-12T15:55:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "GIVN"], "_sharemaestro": {"country": "Switzerland", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "GIVN", "name": "Givaudan SA", "sentiment_url": "https://sharemaestro.com/sentiment/ae280d62-8f03-44ca-adf8-a4acf0559370/"}]}}, {"id": "source:55dbed5d3c43d81c7484cc84af4c0ea094f5a4393865e303ba587743027088f7", "url": "https://finance.yahoo.com/markets/stocks/articles/pierre-vacances-center-parcs-total-133700984.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/pierre-vacances-center-parcs-total-133700984.html", "title": "Pierre & Vacances-Center Parcs: Total Number of Shares and Voting Rights", "content_text": "Pursuant to Article L. 233-8 of the French Commercial Code and Article 223-16 of the General Regulations of the French Autorit\u00e9 des march\u00e9s financiers PARIS, August 12, 2026--(BUSINESS WIRE)--Regulatory News: Pierre & Vacances-Center Parcs (Paris:VAC): Date Number of shares(*) Number of theoretical voting rights Number of actual voting rights (exercisable at General Meetings) (**) 31 July 2026 462 008 714 462 008 714 461 904 805 (*) Ordinary shares only, i.e. excluding 1,130 preferred shares not admitted to trading. (**) Excluding treasury shares, which are deprived of voting rights (the 1,130 preferred shares not carrying voting rights and are not being taken into account). PIERRE ET VACANCES Soci\u00e9t\u00e9 anonyme with a share capital 4,620,098,44 euros Si\u00e8ge social : L'Artois \u2013 11 rue de Cambrai \u2013 75947 Paris Cedex 19 316 580 869 R.C.S. Paris View source version on businesswire.com: https://www.businesswire.com/news/home/20260812714647/en/ Contacts Pierre & Vacances-Center Parcs View Comments", "date_published": "2026-08-12T13:37:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "GIVN"], "_sharemaestro": {"country": "Switzerland", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "GIVN", "name": "Givaudan SA", "sentiment_url": "https://sharemaestro.com/sentiment/ae280d62-8f03-44ca-adf8-a4acf0559370/"}]}}, {"id": "source:e36d474eb97ad2c336075d3dfe5a331dd95140d361056163840fbc0c12cb09bc", "url": "https://finance.yahoo.com/markets/stocks/articles/changes-full-guidance-biomar-113300186.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/changes-full-guidance-biomar-113300186.html", "title": "Changes to full-year guidance for BioMar", "content_text": "Aktieselskabet Schouw & Co. Today, BioMar has released an announcement with updated guidance for the full year 2026. BioMar now expects revenue in the range of DKK 17-18 billion against previously DKK 16-17 billion and EBIT in the range of DKK 1,200-1,300 million compared to previously DKK 1,100-1,200 million. BioMar constitutes a material part of the portfolio and is fully consolidated into the Schouw & Co. figures, and the information from BioMar will be incorporated into Schouw & Co.'s guidance. Schouw & Co. provides guidance to the market on revenue and EBITDA and will consider its consolidated full-year guidance based on the information from BioMar and the outlook for the other portfolio businesses no later than in connection with the release of the interim report scheduled on 14 August 2026. Aktieselskabet Schouw & Co. J\u00f8rgen Wisborg, Chairman of the Board of Directors Jens Bjerg S\u00f8rensen, President & CEO Please direct any questions to President Jens Bjerg S\u00f8rensen, telephone no. +45 86 11 22 22. Attachment 2026-08-12 FBM26-45 BioMar guidance ENG View Comments", "date_published": "2026-08-12T11:33:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "GIVN"], "_sharemaestro": {"country": "Switzerland", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "GIVN", "name": "Givaudan SA", "sentiment_url": "https://sharemaestro.com/sentiment/ae280d62-8f03-44ca-adf8-a4acf0559370/"}]}}, {"id": "source:71a851c14fd85444c47c17893916ebe1b0fe76ccc4bc8e8a0c6e38fcf0f08afb", "url": "https://finance.yahoo.com/markets/stocks/articles/technotrans-se-wbo-ttr1-q2-010228002.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/technotrans-se-wbo-ttr1-q2-010228002.html", "title": "technotrans SE (WBO:TTR1) (Q2 2026) Earnings Call Highlights: Margin Resilience and Strategic ...", "content_text": "This article first appeared on GuruFocus. Revenue: EUR113.3 million in H1 2026, down 6% from EUR120.6 million in the prior year. EBIT: EUR8.0 million in H1 2026, compared to EUR8.4 million one year ago. EBIT Margin: Increased to 7.1% from 7.0% in the prior year. Gross Profit: EUR34.2 million, with gross margin improving to 30.2% from 29.8%. EBITDA: EUR11.2 million, compared to EUR11.9 million in the previous year; EBITDA margin rose to 9.9% from 9.8%. Net Profit: EUR4.9 million, down from EUR5.2 million in the prior year. Earnings Per Share: EUR0.71, compared to EUR0.75 in the previous year. Free Cash Flow: EUR0.5 million in H1 2026, down from EUR1.1 million in the prior year; positive at EUR0.9 million in Q2. Order Backlog: EUR96 million at the end of June, up 14% from the end of March. Book-to-Bill Ratio: 1.2, with order intake exceeding revenue by 20%. Technology Segment Revenue: EUR84 million, down from EUR90.8 million; segment EBIT margin improved to 4.4% from 4.3%. Services Segment Revenue: EUR29.4 million, close to the prior year's EUR29.8 million; EBIT margin remained high at 14.7%. Energy Management and Laser Revenue: Approximately EUR32 million, up 8% year-over-year; excluding laser, growth was 17%. Healthcare and Analytics Revenue: Approximately EUR17 million, up 6% year-over-year. Print Revenue: EUR36 million, down approximately 10% year-over-year. Plastics Revenue: Approximately EUR26 million, down 19% year-over-year. Equity Ratio: Solid at 63.6%. Net Debt: EUR14.5 million, up from EUR8.3 million at the end of 2025; net debt to EBITDA ratio at 0.62. Warning! GuruFocus has detected 7 Warning Signs with JSEJF. Is WBO:TTR1 fairly valued? Test your thesis with our free DCF calculator. Release Date: August 04, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points EBIT margin improved to 7.1% despite a 6% revenue decline, marking the seventh consecutive quarter of stable margins around 7%. Order backlog surged 14% to EUR96 million, with a book-to-bill ratio of 1.2, indicating strong future revenue visibility. Energy Management division grew 17% (excluding laser), driven by robust demand in data center liquid cooling and battery thermal management. Secured a major long-term plastics order with recurring revenue of over EUR10 million annually, plus several large cooling plant orders. Healthcare & Analytics revenue rose 6%, supported by a new liquid cooling system for CT scanners with orders exceeding expectations in Asia. Story Continues Negative Points Group revenue fell 6% to EUR113.3 million, primarily due to continued weakness in Print and Plastics markets. Plastics division suffered a 19% revenue decline, reflecting weak economic conditions and prolonged market downturn. Supply chain restrictions for heat exchangers, pumps, and compressors pose a risk to production and could impact second-half performance. Free cash flow turned positive only in Q2, with first-half cash flow at EUR0.5 million, impacted by working capital buildup. Management expects full-year revenue to likely land in the lower half of the EUR240-260 million guidance range due to ongoing market volatility. Q & A Highlights Q: Given the strong order intake, is it fair to assume the 2027 growth rate will exceed the H2 2026 growth rate?A: Michael Finger (CEO): Yes. The strategic wins, including the significant jump in plastics revenue which will be fully in place next year, will make a difference. Assuming market conditions stay stable and other markets perform as they have this year, we see a nice growth rate in 2027. Q: Can you shed light on which of the larger orders are reflected in the Q2 order backlog and which come on top? Will Q3 also see a positive book-to-bill ratio?A: Michael Finger (CEO): The EUR96 million order backlog reflects only the first half. The major plastics order announced last week is not included and comes on top. Regarding Q3, one month is done and we see a posit", "date_published": "2026-08-12T01:02:28+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "GIVN"], "_sharemaestro": {"country": "Switzerland", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "GIVN", "name": "Givaudan SA", "sentiment_url": "https://sharemaestro.com/sentiment/ae280d62-8f03-44ca-adf8-a4acf0559370/"}]}}, {"id": "source:ea7e7c83c69cf0488590973f55b3e45a00e458be651cdf2ada60e1789a419701", "url": "https://finance.yahoo.com/technology/articles/sbo-strengthens-position-3d-metal-211539467.html", "external_url": "https://finance.yahoo.com/technology/articles/sbo-strengthens-position-3d-metal-211539467.html", "title": "SBO Strengthens Position in 3D Metal Printing: Expanded Capacity in the US and the UK, Award for 3T", "content_text": "TERNITZ, AUSTRIA - August 11, 2026 (NEWMEDIAWIRE) - SBO AG, listed on the leading index ATX of the Vienna Stock Exchange, is expanding its 3D metal printing capacity in the US and the UK and strengthening its market position in Europe through an award for its subsidiary 3T. Both steps advance SBO's diversification strategy in the growing additive manufacturing market. In the US, SBO has expanded additive manufacturing capacity by adding one VELO XC and two Renishaw 500Q printers for high-performance alloys Inconel and Titanium in Q2 2026. In addition, two more VELO XC printers have been ordere", "date_published": "2026-08-11T21:15:39+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "EMSN"], "_sharemaestro": {"country": "Switzerland", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "EMSN", "name": "EMS-CHEMIE HOLDING AG", "sentiment_url": "https://sharemaestro.com/sentiment/12f49923-55c4-41ca-90eb-c40744f4fa80/"}]}}, {"id": "source:8bff636033b9a135246cd57fe0761b00a58cc843c827483397f6e1377ad897ea", "url": "https://finance.yahoo.com/markets/stocks/articles/tecan-group-ag-tchbf-h1-150026054.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/tecan-group-ag-tchbf-h1-150026054.html", "title": "Tecan Group AG (TCHBF) (H1 2026) Earnings Call Highlights: Strategic Progress and Market ...", "content_text": "This article first appeared on GuruFocus. Release Date: August 11, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Tecan Group AG (TCHBF) delivered solid above-market growth in both segments, with group sales up 3.4% in local currencies and order entry up 3%, maintaining a book-to-bill ratio above 1. The company's adjusted EBITDA margin improved slightly to 15.1%, despite significant headwinds from FX and tariffs, with underlying profitability up 108 basis points due to higher volumes, favorable product mix, and initial ", "date_published": "2026-08-11T15:00:26+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "EMSN"], "_sharemaestro": {"country": "Switzerland", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "EMSN", "name": "EMS-CHEMIE HOLDING AG", "sentiment_url": "https://sharemaestro.com/sentiment/12f49923-55c4-41ca-90eb-c40744f4fa80/"}]}}, {"id": "source:307c68c8377bcf013ad783581ce907b734df56f45e0558685346ed0bf0510ade", "url": "https://finance.yahoo.com/healthcare/articles/regn-soars-21-9-month-143000494.html", "external_url": "https://finance.yahoo.com/healthcare/articles/regn-soars-21-9-month-143000494.html", "title": "REGN Soars 21.9% in a Month: Buy, Sell or Hold the Stock?", "content_text": "The going has been strong for Regeneron Pharmaceuticals REGN over the past month. Shares of this biotech giant have surged 21.9% over the said time frame, outpacing the industry's growth of 4%. The stock has also outperformed the sector and the S&P 500 Index during this time. REGN's robust rally has been driven by better-than-expected quarterly results, which can be attributed to robust demand for Eylea HD (higher dose of Eylea) and higher profit-sharing from Dupixent that helped the company mitigate the decline in Eylea sales. REGN Outperforms Industry, Sector and S&P 500 IndexZacks Investment Research Image Source: Zacks Investment Research Against this backdrop, a closer evaluation of the company's strengths and weaknesses can help assess its attractiveness as an investment opportunity. REGN's Eylea HD Gains Traction as Eylea Sales Decline While lead drug Eylea continues to face headwinds, Eylea HD is gaining traction, supported by steady label expansions. Eylea is an anti-VEGF therapy approved across multiple ophthalmology indications. Declining sales of this drug continue to pressure the company's overall revenues. Competitive pressure has intensified, particularly from Roche's RHHBY Vabysmo, which targets both angiopoietin-2 (Ang-2) and VEGF-A pathways and has gained meaningful traction in the retinal disease market. RHHBY's Vabysmo sales grew 8% to CHF 2 billion in the first half of 2026 on continued global growth. To combat the decline in Eylea sales, Regeneron introduced Eylea HD, a higher-dose formulation of Eylea designed to improve durability and extend dosing intervals, Eylea HD sales in the United States surged 52% year over year to $596 million in the second quarter of 2026, driven by strong uptake following recent FDA label expansions and growing physician confidence in its differentiated profile and flexible dosing regimen. In April 2026, the FDA approved the extension of dosing intervals for Eylea HD to up to every 20 weeks (5 months) for patients with wet age-related macular degeneration (wAMD) and diabetic macular edema (DME) following a year of successful response based on visual and anatomic outcomes. The regulatory body had earlier approved Eylea HD for the treatment of macular edema following retinal vein occlusion (RVO), with dosing of up to once every eight weeks after an initial monthly dosing phase. The FDA also approved a monthly dosing option for certain patients who may benefit from resuming this dosing schedule across all currently approved indications, including wet age-related macular degeneration, DME, diabetic retinopathy and RVO. Story Continues Eylea and Eylea HD were co-developed with Bayer BAYRY. Regeneron records net product sales in the United States, while Bayer records sales outside the country. It expects a further decline in Eylea sales in the second half of 2026 due to ongoing conversion to Eylea HD and increasing competition as multiple biosimilar versions enter the U.S. market. Strong Dupixent Sales Fuel REGN Profits REGN's top line also comprises its share of profits/losses in connection with the global sales of Dupixent. Partner Sanofi records global net product sales of Dupixent. Dupixent continues to deliver strong growth across key indications, including atopic dermatitis, asthma, nasal polyps and eosinophilic esophagitis, while newer uses such as COPD, chronic spontaneous urticaria, bullous pemphigoid and allergic fungal rhinosinusitis are gaining traction. Ongoing label expansions for Dupixent remain a key contributor to revenue visibility and profitability. Regeneron Strengthens Its Oncology Portfolio Regeneron's oncology franchise is anchored by its PD-1 inhibitor Libtayo (cemiplimab-rwlc), which is approved for use in certain patients with advanced basal cell carcinoma (BCC), advanced cutaneous squamous cell carcinoma (CSCC) and advanced non-small cell lung cancer (NSCLC). Libtayo sales continue to be robust, driven by strength across non-melanoma skin cancers and NSCL", "date_published": "2026-08-11T14:30:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "GIVN"], "_sharemaestro": {"country": "Switzerland", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "GIVN", "name": "Givaudan SA", "sentiment_url": "https://sharemaestro.com/sentiment/ae280d62-8f03-44ca-adf8-a4acf0559370/"}]}}, {"id": "source:90fd1a4b29b52997dbd3d887a514a6138065282e4c9262f48f3e8caf3752b1fc", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1hR3BiNDljM2s2eFFlVnhxTFVpcmZmSkhMWnRxVUl5a3Q1LXc1dW5TV0ZXdVo0VUd5X01hZEg3WU1rTFJUVm1YWmhaZ3NIYV9XcU00?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1hR3BiNDljM2s2eFFlVnhxTFVpcmZmSkhMWnRxVUl5a3Q1LXc1dW5TV0ZXdVo0VUd5X01hZEg3WU1rTFJUVm1YWmhaZ3NIYV9XcU00?oc=5", "title": "SIKA AKTIE: AI-Analysen, Prognose & Kursziel", "content_text": "SIKA AKTIE: AI-Analysen, Prognose & Kursziel", "date_published": "2026-08-10T15:44:43+00:00", "authors": [{"name": "finanzen.net"}], "tags": ["Market update", "SIKA"], "_sharemaestro": {"country": "Switzerland", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SIKA", "name": "Sika AG", "sentiment_url": "https://sharemaestro.com/sentiment/e6c814a5-97bc-4e61-b3d9-bde158ce5a93/"}]}}, {"id": "source:3e0772535bcd8c8e707ef12cda9121cba128cda4634795987bd2490ecd9945ab", "url": "https://finance.yahoo.com/markets/stocks/articles/aspo-plc-managers-transactions-143000320.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/aspo-plc-managers-transactions-143000320.html", "title": "Aspo Plc - Managers' Transactions", "content_text": "Aspo Plc Aspo Plc Managers' transactions August 10, 2026 at 17.30 EET Aspo Plc - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: AEV Capital Holding Oy Position: Member of the Board/Deputy member (X) Legal person (1): Person Discharging Managerial Responsibilities In Issuer Name: Tatu Vehmas Position: Member of the Board/Deputy member Issuer: Aspo Oyj LEI: 7437000TB0GHDHLPX677 Notification type: INITIAL NOTIFICATION Reference number: 168845/7/4 ____________________________________________ Transaction date: 2026-08-06 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI0009008072 Nature of transaction: ACQUISITION Transaction details (1): Volume: 50000 Unit price: 7 EUR Aggregated transactions (1): Volume: 50000 Volume weighted average price: 7 EUR Aspo Plc Distribution: Nasdaq Helsinki www.aspo.com For more information, please contact: Taru Uotila, SVP, Legal and Sustainability, Aspo Plc, tel. +358 40 8622 318, taru.uotila@aspo.com Aspo creates value by owning and developing business operations sustainably and in the long term. Aspo's businesses \u2013 ESL Shipping and Telko \u2013 enable future-proof, sustainable choices for customers in various industries. Established in 1929, today we are together about 650 experts on land and at sea. While the Nordic region is our core market, we serve our customers with world-class solutions in 18 countries around Europe and parts of Asia. Aspo is listed on Nasdaq Helsinki and is headquartered in Finland. Aspo \u2013 Sustainable value creation View Comments", "date_published": "2026-08-10T14:30:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "GIVN"], "_sharemaestro": {"country": "Switzerland", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "GIVN", "name": "Givaudan SA", "sentiment_url": "https://sharemaestro.com/sentiment/ae280d62-8f03-44ca-adf8-a4acf0559370/"}]}}, {"id": "source:b0ae47e3109f7853937d8d41314cf0e18cb76e7231ad53dde7a16ea62f11edc1", "url": "https://news.google.com/rss/articles/CBMidEFVX3lxTE1kd1JpN0Z5MVg1SWJUQlRZVzJNV3lYV2JlYldsSzZmSDVnUWxaV3NCdDMyY0t4TjRPTTg3ZFFLdGRWaUJyOEhhVGtwdVVMWUd1dU9VZ1VUMkNNV3RveC1tRjdieEdFRVhhc2UyeDVCV0hYZmpi?oc=5", "external_url": "https://news.google.com/rss/articles/CBMidEFVX3lxTE1kd1JpN0Z5MVg1SWJUQlRZVzJNV3lYV2JlYldsSzZmSDVnUWxaV3NCdDMyY0t4TjRPTTg3ZFFLdGRWaUJyOEhhVGtwdVVMWUd1dU9VZ1VUMkNNV3RveC1tRjdieEdFRVhhc2UyeDVCV0hYZmpi?oc=5", "title": "SIKA Prognose \u2014 Kursziel f\u00fcr 2027", "content_text": "SIKA Prognose \u2014 Kursziel f\u00fcr 2027", "date_published": "2026-06-26T05:22:43+00:00", "authors": [{"name": "TradingView"}], "tags": ["Market update", "SIKA"], "_sharemaestro": {"country": "Switzerland", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SIKA", "name": "Sika AG", "sentiment_url": "https://sharemaestro.com/sentiment/e6c814a5-97bc-4e61-b3d9-bde158ce5a93/"}]}}, {"id": "source:a270a3ab59e816093da94d810a3675785978f10718051c830c381696e325b67d", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTE9kTWYxbnJHaXd3Z2lNOGRfczZ5ZklEZm9WaVEycldpWTVhOG52QUNmaHEydlNkcXZfZFlaN3FKWHE5anNhMzdSLQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTE9kTWYxbnJHaXd3Z2lNOGRfczZ5ZklEZm9WaVEycldpWTVhOG52QUNmaHEydlNkcXZfZFlaN3FKWHE5anNhMzdSLQ?oc=5", "title": "Sika AG Aktie Kurs & Chart A2JNV8", "content_text": "Sika AG Aktie Kurs & Chart A2JNV8", "date_published": "2026-01-29T03:59:50+00:00", "authors": [{"name": "Goldesel.de"}], "tags": ["Market update", "SIKA"], "_sharemaestro": {"country": "Switzerland", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SIKA", "name": "Sika AG", "sentiment_url": "https://sharemaestro.com/sentiment/e6c814a5-97bc-4e61-b3d9-bde158ce5a93/"}]}}, {"id": "source:8ebd93c5a8d1e472da0ffc3527535290e46c8ca47211aff075827b4fc3118833", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPNjJxVTdETks3YWI0dFViWU9fTVBNSkJwRHBOWlpxTloxVWM1T0hCOHU2YVcxYlhuWGlpMWI1bjBoUWNiZEJpcjB1YU1ybDBIZEI3Z3RwOGZSREhtRkxVdlEwWXd0d01NVVh5QTRjSHAwY0VTejlmazM3bVIzd05aWUd1SEVYQWt3?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPNjJxVTdETks3YWI0dFViWU9fTVBNSkJwRHBOWlpxTloxVWM1T0hCOHU2YVcxYlhuWGlpMWI1bjBoUWNiZEJpcjB1YU1ybDBIZEI3Z3RwOGZSREhtRkxVdlEwWXd0d01NVVh5QTRjSHAwY0VTejlmazM3bVIzd05aWUd1SEVYQWt3?oc=5", "title": "Clariant AG: Dividendenhistorie und Prognosen", "content_text": "Clariant AG: Dividendenhistorie und Prognosen", "date_published": "2024-07-23T11:10:05+00:00", "authors": [{"name": "MarketScreener Deutschland"}], "tags": ["Market update", "CLN"], "_sharemaestro": {"country": "Switzerland", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "CLN", "name": "Clariant AG", "sentiment_url": "https://sharemaestro.com/sentiment/68b785d1-b026-4e3c-8ce9-4242f55660c2/"}]}}, {"id": "source:47606c78cf342722ae3d216b6696a6e5f2ede749908b43bf17c6a0e16590c552", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE8zVkh3cGtWUGFaeUlPZTFjM0hxZ1RGbjAySGI3LUxuRzVoNWhqaFdVcTNneHJfV0xUdDhkMExRU1M2OGdrQkJRMnprN2JWdWd0ZzNBeE5RRjhCc25fMnB4LXQwbXJDRDN1eER4SDBkWUlPN1h0SS1NV3pn?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE8zVkh3cGtWUGFaeUlPZTFjM0hxZ1RGbjAySGI3LUxuRzVoNWhqaFdVcTNneHJfV0xUdDhkMExRU1M2OGdrQkJRMnprN2JWdWd0ZzNBeE5RRjhCc25fMnB4LXQwbXJDRDN1eER4SDBkWUlPN1h0SS1NV3pn?oc=5", "title": "Clariant AG: Finanzdaten Prognosen Sch\u00e4tzungen und Erwartungen | 895929 | CH0012142631", "content_text": "Clariant AG: Finanzdaten Prognosen Sch\u00e4tzungen und Erwartungen | 895929 | CH0012142631", "date_published": "2024-07-23T07:39:49+00:00", "authors": [{"name": "MarketScreener Schweiz"}], "tags": ["Market update", "CLN"], "_sharemaestro": {"country": "Switzerland", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "CLN", "name": "Clariant AG", "sentiment_url": "https://sharemaestro.com/sentiment/68b785d1-b026-4e3c-8ce9-4242f55660c2/"}]}}, {"id": "source:7d4d38dad0c31ca2e453a27735cf46001f616ba6d713a8bc97c644a519676e06", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE5qd2gxYWUzVkZSY1B0ajY3RU5DVUVtLTZxTERSRGIxYlZWVktpaWNXc0Y4b2hHbXBRR0djTm1hN080eU1ybFNXd1pxbHpPRTd3NV9iZURqU0d0WjNSQzhCRURPR25lVlFRRFpLZnRJNGJ1QnRLaVE?oc=5", "external_url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE5qd2gxYWUzVkZSY1B0ajY3RU5DVUVtLTZxTERSRGIxYlZWVktpaWNXc0Y4b2hHbXBRR0djTm1hN080eU1ybFNXd1pxbHpPRTd3NV9iZURqU0d0WjNSQzhCRURPR25lVlFRRFpLZnRJNGJ1QnRLaVE?oc=5", "title": "Sika AG: Finanzdaten Prognosen Sch\u00e4tzungen und Erwartungen | A2JNV8 | CH0418792922", "content_text": "Sika AG: Finanzdaten Prognosen Sch\u00e4tzungen und Erwartungen | A2JNV8 | CH0418792922", "date_published": "2024-07-23T07:28:21+00:00", "authors": [{"name": "MarketScreener Schweiz"}], "tags": ["Market update", "SIKA"], "_sharemaestro": {"country": "Switzerland", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SIKA", "name": "Sika AG", "sentiment_url": "https://sharemaestro.com/sentiment/e6c814a5-97bc-4e61-b3d9-bde158ce5a93/"}]}}, {"id": "source:55613df6b33c962229026c433fb1fcbba3e7f0be825b008ed0bac1f98a7821ae", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxOYXJYVEQ0S3ZsXzJLTmZLV091Y3ZUVXFHdkpLQjU5T1ktMFBPMjZPLU83b0liVmZTNW80SFUzdEh1WDE0NzRHbEtWaWJqXzRHTlZQSE0yNzUxVk8xYzZ4RkUtdXhGelA1TzFueGtxUWRUU3BqdThraE53dGRFUXRxX3ZnMHRIRUJoYnc?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxOYXJYVEQ0S3ZsXzJLTmZLV091Y3ZUVXFHdkpLQjU5T1ktMFBPMjZPLU83b0liVmZTNW80SFUzdEh1WDE0NzRHbEtWaWJqXzRHTlZQSE0yNzUxVk8xYzZ4RkUtdXhGelA1TzFueGtxUWRUU3BqdThraE53dGRFUXRxX3ZnMHRIRUJoYnc?oc=5", "title": "Clariant AG: Konsensus der Analysten und Kursziel | 895929 | CH0012142631", "content_text": "Clariant AG: Konsensus der Analysten und Kursziel | 895929 | CH0012142631", "date_published": "2020-08-19T06:47:49+00:00", "authors": [{"name": "MarketScreener Schweiz"}], "tags": ["Market update", "CLN"], "_sharemaestro": {"country": "Switzerland", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "CLN", "name": "Clariant AG", "sentiment_url": "https://sharemaestro.com/sentiment/68b785d1-b026-4e3c-8ce9-4242f55660c2/"}]}}, {"id": "source:d0c9cff34578f74a62157085673cbdf8eee695ec4f5d2f216b370ddbe4a9f86d", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPT3hQeEN5aVBleUdPbWpBX3c2OUlKVkV3dkp4RVVsN3dpWHVBUkttU2FCSlh2SHVDQk5MMkp1U1lVelAwZ0tYeDFtaVFJWTMwMFBnWVJ3T2t4d08xaXV1RktLTUw0clZoRHNVNk00aWJOQ3czV1FoM3l2QUZyaGZpQlJ4cW9yQQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPT3hQeEN5aVBleUdPbWpBX3c2OUlKVkV3dkp4RVVsN3dpWHVBUkttU2FCSlh2SHVDQk5MMkp1U1lVelAwZ0tYeDFtaVFJWTMwMFBnWVJ3T2t4d08xaXV1RktLTUw0clZoRHNVNk00aWJOQ3czV1FoM3l2QUZyaGZpQlJ4cW9yQQ?oc=5", "title": "Sika AG: Konsensus der Analysten und Kursziel | A2JNV8 | CH0418792922", "content_text": "Sika AG: Konsensus der Analysten und Kursziel | A2JNV8 | CH0418792922", "date_published": "2020-08-19T04:39:50+00:00", "authors": [{"name": "MarketScreener Schweiz"}], "tags": ["Market update", "SIKA"], "_sharemaestro": {"country": "Switzerland", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SIKA", "name": "Sika AG", "sentiment_url": "https://sharemaestro.com/sentiment/e6c814a5-97bc-4e61-b3d9-bde158ce5a93/"}]}}, {"id": "source:f602823ff9647fb45e03401f91368ffcd643cddfa8d84c034aa52809a2f64e37", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE9oR2RBbXFxcDlXQ3FTWHcybElkQm5ONkdOZUZZem1qaElpUTgxOXRuQnptOFBvRzZ4Y3MzNmtJREVMcDZKTElFU3hteC1vRlJt?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE9oR2RBbXFxcDlXQ3FTWHcybElkQm5ONkdOZUZZem1qaElpUTgxOXRuQnptOFBvRzZ4Y3MzNmtJREVMcDZKTElFU3hteC1vRlJt?oc=5", "title": "Clariant AG (CLN.ZU) Aktienkurs, Nachrichten & Analystensch\u00e4tzungen", "content_text": "Clariant AG (CLN.ZU) Aktienkurs, Nachrichten & Analystensch\u00e4tzungen", "date_published": "2019-10-26T10:31:55+00:00", "authors": [{"name": "eToro"}], "tags": ["Market update", "CLN"], "_sharemaestro": {"country": "Switzerland", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "CLN", "name": "Clariant AG", "sentiment_url": "https://sharemaestro.com/sentiment/68b785d1-b026-4e3c-8ce9-4242f55660c2/"}]}}, {"id": "source:068d04113130789766118da1edda312371dbe7b8f0dad186409e34b2a4ffc5d3", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE9YWm1TeVVUYS1obXFkZ3BwTmNpN0ZLc3VValRYTS1ncXNVZVo4czhhaGlteHRwZVlZUFh3UFdNWWhxaDRGcTMta0tyQVByTXFVYWlqeW1nNHpkOHpr?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE9YWm1TeVVUYS1obXFkZ3BwTmNpN0ZLc3VValRYTS1ncXNVZVo4czhhaGlteHRwZVlZUFh3UFdNWWhxaDRGcTMta0tyQVByTXFVYWlqeW1nNHpkOHpr?oc=5", "title": "Sika AG Aktie: Aktienkurs & Charts", "content_text": "Sika AG Aktie: Aktienkurs & Charts", "date_published": "2019-04-08T17:06:24+00:00", "authors": [{"name": "Comdirect"}], "tags": ["Market update", "SIKA"], "_sharemaestro": {"country": "Switzerland", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SIKA", "name": "Sika AG", "sentiment_url": "https://sharemaestro.com/sentiment/e6c814a5-97bc-4e61-b3d9-bde158ce5a93/"}]}}]}